...
CELCMID

Celcuity Inc.

HealthcareBiotechnology
$111.71
$0.01(+0.53%)
52W$7.58
$120.31
Updated Mar 1, 12:00 AM
RSI59
RS Rating98/99
Beta1.08
Volatility69%
F-Score1/9
Mkt Cap$4.8B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Celcuity Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 98), indicating clear outperformance against the broad market. Earnings contraction of 31% provides fundamental context to the price action. Investors should exercise caution due to high volatility (69% annualized), which requires wider risk management.

Relative Strength
98
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
1.08
vs S&P 500
MARKET
52W Position
92%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$106.30
50 SMA > 100 SMA$93.76
100 SMA > 150 SMA$79.24
150 SMA > 200 SMA$62.51

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$106.92+4.48%ABOVE
50 SMA$106.30+5.09%ABOVE
100 SMA$93.76+19.14%ABOVE
150 SMA$79.24+40.98%ABOVE
200 SMA$62.51+78.69%ABOVE

Price Performance

1D+0.5%
1W+6.2%
1M-2.5%
3M+10.5%
6M+104.6%
YTD+11.1%
1Y+10.8%
3Y+111.7%
52-Week Trading Range92% from low
$111.71
52W Low$7.58
52W High$120.31

Technical Indicators

RSI (14)NEUTRAL
59.2
305070
VCP ScoreWARM
8/10
Base depth: 20.6%

Risk Profile

Beta
1.08
52W Vol
69%
ATR
$4.69
Max DD (1Y)
-28%

Volume Analysis

Today
111
50D Avg
610.1K
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q4'24-31%
$-0.85
Q1'25-34%
$-0.86
Q2'25-68%
$-1.04
Q3'25-31%
$-0.92
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-40.61%

Stock Price CAGR

10 Years:+22.83%
5 Years:+50.00%
3 Years:+111.66%
1 Year:+10.85%

Return on Equity

10Y Avg:-50.9%
5Y Avg:-61.8%
3Y Avg:-58.0%
Last Year:-139.1%

Key Metrics

Market Cap$4.8B
Gross Margin
Net Margin
Piotroski F-Score1/9

Frequently Asked Questions

Is CELC in an uptrend right now?

CELC has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, CELC is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is CELC overbought or oversold?

CELC's RSI (14) is 59. The stock is in neutral territory, neither overbought nor oversold.

Is CELC outperforming the market?

CELC has a Relative Strength (RS) Rating of 98 out of 99. Yes, CELC is a market leader, outperforming 98% of all stocks over the past 12 months.

Where is CELC in its 52-week range?

CELC is trading at $111.71, which is 93% of its 52-week high ($120.31) and 92% above its 52-week low ($7.58).

How volatile is CELC?

CELC has a Beta of 1.08 and 52-week volatility of 69%. It's more volatile than the S&P 500 - expect bigger swings.